Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy

Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy

Abstract Invasive lobular carcinoma comprises 10–15% of all breast cancers and is increasingly recognised as a distinct and understudied disease compared with the predominant histological subtype, invasive ductal carcinoma. Hallmarks of invasive lobular carcinoma include E-cadherin loss, leading to...

Full description

Bibliographic Details
Main Authors: Jocelyn Luveta, Ruth M. Parks, David M. Heery, Kwok-Leung Cheung, Simon J. Johnston
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-12-01
Series:Oncology and Therapy
Subjects:
Aromatase inhibitors
Breast cancer
Endocrine therapy
Histology
Immunotherapy
Invasive lobular carcinoma
Online Access:https://doi.org/10.1007/s40487-019-00105-0

Internet

https://doi.org/10.1007/s40487-019-00105-0

Similar Items